Advertisement
New Zealand markets closed
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NZD/USD

    0.5899
    -0.0007 (-0.11%)
     
  • NZD/EUR

    0.5528
    -0.0016 (-0.29%)
     
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • OIL

    82.89
    +0.16 (+0.19%)
     
  • GOLD

    2,407.00
    +9.00 (+0.38%)
     
  • NASDAQ

    17,195.69
    -198.62 (-1.14%)
     
  • FTSE

    7,894.48
    +17.43 (+0.22%)
     
  • Dow Jones

    37,962.79
    +187.41 (+0.50%)
     
  • DAX

    17,739.95
    -97.45 (-0.55%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • NZD/JPY

    91.1280
    -0.1260 (-0.14%)
     

This Cancer Drug Candidate Could Be a Hit for Pfizer

This Cancer Drug Candidate Could Be a Hit for Pfizer

The FDA recently accepted the drugmaker's regulatory filing for review of a potential drug to treat a type of blood cancer.